| Product Code: ETC7634918 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Multiple Myeloma Drugs Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Multiple Myeloma Drugs Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Multiple Myeloma Drugs Market - Industry Life Cycle |
3.4 Ireland Multiple Myeloma Drugs Market - Porter's Five Forces |
3.5 Ireland Multiple Myeloma Drugs Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.6 Ireland Multiple Myeloma Drugs Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.7 Ireland Multiple Myeloma Drugs Market Revenues & Volume Share, By End-User, 2021 & 2031F |
3.8 Ireland Multiple Myeloma Drugs Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Ireland Multiple Myeloma Drugs Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence and prevalence of multiple myeloma in Ireland |
4.2.2 Advancements in drug development and targeted therapies for multiple myeloma |
4.2.3 Growing awareness and diagnosis rates of multiple myeloma in the country |
4.3 Market Restraints |
4.3.1 High cost of multiple myeloma drugs and treatment |
4.3.2 Stringent regulations and approval processes for new drugs in Ireland |
4.3.3 Limited access to specialized healthcare facilities in certain regions |
5 Ireland Multiple Myeloma Drugs Market Trends |
6 Ireland Multiple Myeloma Drugs Market, By Types |
6.1 Ireland Multiple Myeloma Drugs Market, By Therapy |
6.1.1 Overview and Analysis |
6.1.2 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Therapy, 2021- 2031F |
6.1.3 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Targeted Therapy, 2021- 2031F |
6.1.4 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Biologic Therapy, 2021- 2031F |
6.1.5 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.1.6 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Ireland Multiple Myeloma Drugs Market, By Drug Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Immunomodulatory Drugs, 2021- 2031F |
6.2.3 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Proteasome Inhibitors, 2021- 2031F |
6.2.4 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Histone Deacetylase Inhibitors, 2021- 2031F |
6.2.5 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Monoclonal Antibody Drugs, 2021- 2031F |
6.2.6 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Steroids, 2021- 2031F |
6.2.7 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Ireland Multiple Myeloma Drugs Market, By End-User |
6.3.1 Overview and Analysis |
6.3.2 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Men, 2021- 2031F |
6.3.3 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Women, 2021- 2031F |
6.4 Ireland Multiple Myeloma Drugs Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.4.3 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.4.4 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.4.5 Ireland Multiple Myeloma Drugs Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Multiple Myeloma Drugs Market Import-Export Trade Statistics |
7.1 Ireland Multiple Myeloma Drugs Market Export to Major Countries |
7.2 Ireland Multiple Myeloma Drugs Market Imports from Major Countries |
8 Ireland Multiple Myeloma Drugs Market Key Performance Indicators |
8.1 Patient survival rates and quality of life improvements with drug treatments |
8.2 Adoption rates of novel therapies for multiple myeloma in Ireland |
8.3 Research and development investments in the multiple myeloma drug market |
9 Ireland Multiple Myeloma Drugs Market - Opportunity Assessment |
9.1 Ireland Multiple Myeloma Drugs Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.2 Ireland Multiple Myeloma Drugs Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.3 Ireland Multiple Myeloma Drugs Market Opportunity Assessment, By End-User, 2021 & 2031F |
9.4 Ireland Multiple Myeloma Drugs Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Ireland Multiple Myeloma Drugs Market - Competitive Landscape |
10.1 Ireland Multiple Myeloma Drugs Market Revenue Share, By Companies, 2024 |
10.2 Ireland Multiple Myeloma Drugs Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here